Skip to main content

COVID-19 Topic Center

Podcasts

Podcasts
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues sought to better describe adult patients with atopic…
Podcasts
Brett Zelkind, senior vice president of business development and Eric Zerneke, chief commercial officer, both at CredSimple, explain why social determinants of health and the uptake in telehealth should be considered throughout the navigation of the pandemic while ensuring compliance as well as…
Podcasts
Tim Lash, chief strategy officer for West Health, discusses the overall cost of health care, including prescription drug prices, and provides a future outlook on where he believes health care prices are going.
Podcasts
Sarah Temkin, MD, board-certified gynecologic oncologist, and Don Dizon, MD, oncologist specializing in women’s cancers, discuss an ongoing Phase III trial that examines the use of selinexor for the treatment of endometrial cancer, and highlight what they hope to see for the future of care.
Podcasts
Sara Hurvitz, MD, medical oncologist, Ronald Reagan UCLA Medical Center, and Sherene Loi, PhD, senior medical oncologist, Peter MacCallum Cancer Center, discuss their recent study, HER2CLIMB, highlighting the positive findings that include the reduction of intracranial progression and death among…
Podcasts
In this episode of PopHealth Perspectives, Kiersten Combs, vice president, US Cardiovascular and Metabolic Disease (US CVMD) and Naeem Khan, MD, vice president, medical, US CVMD, AstraZeneca, discuss the recent approval of Farxiga (dapagliflozin), and explain how this treatment lowers the disease…
Podcasts
Saad Usmani, MD, discusses the recent approval of daratumumab subcutaneous formulation for patients with multiple myeloma, and explains the major benefits of this treatment for this patient population.
Podcasts
In this podcast, Andree Amelsberg, vice president of US Medical Affairs Oncology and Hematology at Janssen, and Danelle James, Imbruvica clinical science lead at Pharmacyclics LLC, an AbbVie company, discuss the recent expanded approval of Imbruvica (ibrutinib) plus rituximab for the treatment of…
Podcasts
Robert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care professionals to get to know all of the available NOACs.
Podcasts
David Henka, president and CEO of ActiveRADAR, an analytics organization that focuses in on drug pricing, discusses why reference pricing for therapeutic medication alternatives is important.
Back to Top